cervical injections
Recently Published Documents


TOTAL DOCUMENTS

9
(FIVE YEARS 0)

H-INDEX

2
(FIVE YEARS 0)

Pain Medicine ◽  
2019 ◽  
Author(s):  
Byron Schneider ◽  
Adrian Popescu ◽  
Clark Smith

2015 ◽  
Vol 123 (5) ◽  
pp. 1133-1141 ◽  
Author(s):  
Kelly A. Pollak ◽  
Linda S. Stephens ◽  
Karen L. Posner ◽  
James P. Rathmell ◽  
Dermot R. Fitzgibbon ◽  
...  

Abstract Background The authors examined changes in the frequency of pain medicine malpractice claims and associated treatment modalities and outcomes over time. Methods The authors analyzed trends in pain medicine claims from 1980 to 2012 in the Anesthesia Closed Claims Project database by binary logistic regression on year of event. Pain procedures in claims from 2000 to 2012 were compared with the proportion of pain procedures reported to the National Anesthesia Clinical Outcomes Registry in 2010–2014. Results Malpractice claims for pain medicine increased from 3% of 2,966 total malpractice claims in the Anesthesia Closed Claims Project database in 1980–1989 to 18% of 2,743 anesthesia claims in 2000–2012 (odds ratio [OR], 1.088 per year; 95% CI, 1.078 to 1.098; P < 0.001). Outcomes in pain claims became more severe over time, with increases in death and permanent disabling injury (OR, 1.094 per year; P < 0.001). Nonneurolytic cervical injections increased to 27% of pain claims in 2000–2012 (OR, 1.054; P < 0.001), whereas National Anesthesia Clinical Outcomes Registry demonstrates that lumbar injections are a more common procedure. Claims associated with medication management increased to 17% of pain claims in 2000–2012 (OR, 1.116 per year; P < 0.001). Conclusions Pain medicine claims have increased over time and have increased in severity. Claims related to cervical procedures were out of proportion to the frequency with which they are performed. These liability findings suggest that pain specialists should aggressively continue the search for safer and more effective therapies.


Author(s):  
Benjamin P. Lowry ◽  
Adam M. Savage
Keyword(s):  

2013 ◽  
Vol 23 (9) ◽  
pp. 1704-1711 ◽  
Author(s):  
Emma C. Rossi ◽  
Amanda Jackson ◽  
Anastasia Ivanova ◽  
John F. Boggess

ObjectiveSentinel lymph node (SLN) mapping with indocyanine green (ICG) detected by robotic near infrared (NIR) imaging is a feasible technique. The optimal site of injection (cervical or endometrial) for endometrial cancer has yet to be determined. We prospectively evaluated SLN mapping after cervical and endometrial injections of ICG to compare the detection rates and patterns of nodal distribution.MethodsTwenty-nine subjects with endometrial cancer undergoing robotic hysterectomy with lymphadenectomy by a single surgeon received SLN mapping with robotic fluorescence imaging. Seventeen patients received cervical injections of 1 mg of ICG and 12 patients received hysteroscopic endometrial injections of 0.5-mg ICG. Detection rates between the 2 groups were compared using Fisher exact tests. Continuous variables such as operating room times and body mass index were compared usingttests.ResultsThe SLN detection rate was 82% (14/17) for cervical and 33% (4/12) for hysteroscopic injection (P= 0.027). Sentinel lymph nodes were seen bilaterally in 57% (8/14) of the cervical injection group and 50% (2/4) of the hysteroscopic group. Para-aortic SLNs were seen in 71% (10/14) of patients who mapped after cervical injection and 75% (3/4) patients who mapped after hysteroscopic injection. There was 1 false-negative SLN in the cervical injection group.ConclusionsCervical ICG injection achieves a higher SLN detection rate and a similar anatomic nodal distribution as hysteroscopic endometrial injection for SLN mapping in patients with endometrial cancer.


2003 ◽  
pp. 59-62
Author(s):  
Jean Carruthrs ◽  
Alastair Carruthrs
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document